Association between the level of serum soluble ST2 and invasively measured aortic pulse pressure in patients undergoing coronary angiography

Medicine
Hack-Lyoung KimSang-Hyun Kim

Abstract

Despite the well-documented value of ST2 in heart failure and myocardial infarction, the role of ST2 in vascular biology has not yet been well defined. This study was performed to investigate the association between serum soluble ST2 (sST2) and invasively measured aortic pulse pressure (APP). A total of 167 consecutive patients with suspected coronary artery disease (CAD) (65.1 ± 9.8 years; men, 65.9%) referred for invasive coronary angiography was prospectively enrolled. APP was measured at the ascending aorta with a pig-tail catheter, and arterial blood samples for the measurement of sST2 were collected before coronary angiography. Serum sST2 levels were quantified by radioimmunoassay. Most of the patients (73.9%) had significant CAD (stenosis ≥ 50%) on coronary angiography. Patients with higher APP (≥76 mmHg) showed a significantly higher sST2 level compared to those with lower APP (<76 mmHg) (31.7 ± 13.9 ng/mL vs 26.2 ± 10.2 ng/mL, P < .001). In simple correlation analysis, there was a significant positive correlation between sST2 levels and APP (r = 0.413, P < .001). In multiple linear regression analysis, sST2 had an independent association with APP even after controlling for potential confounders (β = 0.331, P < .001). T...Continue Reading

References

Mar 27, 2001·Journal of the American College of Cardiology·A M Dart, B A Kingwell
Jul 14, 2001·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·D R TaaffeT B Harris
Mar 19, 2002·Hypertension·Michel E SafarGérard M London
May 23, 2002·American Journal of Hypertension·Tomoshige HayashiHiroyasu Ueda
Mar 6, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology· YasminIan B Wilkinson
Aug 13, 2004·Atherosclerosis·Francesco U S Mattace-RasoJacqueline C M Witteman
Sep 28, 2005·Circulation·Charalambos VlachopoulosChristodoulos Stefanadis
Nov 1, 2006·Advances in Cardiology·Nicolas Danchin, Jean-Jacques Mourad
May 12, 2007·The Journal of Clinical Investigation·Shoji SanadaRichard T Lee
Feb 13, 2008·The Journal of Experimental Medicine·Ashley M MillerFoo Y Liew
Apr 23, 2008·Hypertension·Carmel M McEnieryUNKNOWN Anglo-Cardiff Collaborative Trial Investigators
Nov 20, 2008·Journal of the American College of Cardiology·Shafiq U RehmanJames L Januzzi
Mar 27, 2010·Journal of the American College of Cardiology·Charalambos VlachopoulosChristodoulos Stefanadis
Apr 7, 2010·Cardiovascular Research·Michael MildnerHendrik Jan Ankersmit
Dec 24, 2010·Circulation. Heart Failure·Bonnie KyThomas P Cappola
Aug 17, 2011·Cardiology Research and Practice·Jochen SteppanDaniel Nyhan
Nov 19, 2011·Clinical Chemistry·Payal KohliDavid A Morrow
Dec 3, 2011·Journal of Hypertension·Ulf NeisiusChristian Delles
Apr 26, 2013·Journal of Hypertension·Jennifer E HoJames L Januzzi
Nov 23, 2013·PloS One·Ernesto Martínez-MartínezNatalia López-Andrés

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.